Content » Vol 92, Issue 4

Letter to the Editor

Differential Response of Chronic Plaque Psoriasis to Briakinumab vs. Ustekinumab

Supplementary content
Figure S1
Figure S2
Licenses
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.